Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.9000 (-3.28%) ($5.8500 - $6.3500) on Fri. Aug. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.23% (three month average) | RSI | 52 | Latest Price | $5.9000(-3.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.4% a day on average for past five trading days. | Weekly Trend | ANPC advances 4.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(10%) XLB(10%) IPO(9%) LIT(9%) TLT(8%) | Factors Impacting ANPC price | ANPC will decline at least -4.115% in a week (0% probabilities). SHY(-27%) XLU(-11%) IBB(-9%) XLP(-8%) XBI(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.115% (StdDev 8.23%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.43 | 5 Day Moving Average | $6.57(-10.2%) | 10 Day Moving Average | $6.9(-14.49%) | 20 Day Moving Average | $6.43(-8.24%) | To recent high | -24.8% | To recent low | 15.9% | Market Cap | $50m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |